Acciones Magle Chemoswed Holding AB (publ) Nasdaq Stockholm
Acciones
SE0014401014
Farmacéuticos
Ventas 2024 * | 185 M 16,93 M 15,8 M | Ventas 2025 * | 216 M 19,74 M 18,42 M | Capitalización | 326 M 29,87 M 27,88 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 21 M 1,92 M 1,79 M | Resultado Neto 2025 * | 30 M 2,75 M 2,56 M | VE / Ventas 2024 * | 2,05 x |
Deuda neta 2024 * | 53 M 4,85 M 4,53 M | Deuda neta 2025 * | 42 M 3,85 M 3,59 M | VE / Ventas 2025 * | 1,71 x |
P/E ratio 2024 * |
15,9
x | P/E ratio 2025 * |
10,4
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 21,39 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Justin Pierce
CEO | Chief Executive Officer | 51 | 01/01/15 |
Petra Sjölin
DFI | Director of Finance/CFO | - | 01/07/20 |
Chief Operating Officer | 48 | 01/01/99 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 78 | 01/01/16 | |
Director/Board Member | 79 | 01/01/16 | |
Director/Board Member | 44 | 01/01/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,25 % | 704 mil M | |
+28,59 % | 577 mil M | |
-3,55 % | 348 mil M | |
+18,16 % | 327 mil M | |
+4,36 % | 288 mil M | |
+14,81 % | 234 mil M | |
+4,93 % | 198 mil M | |
-9,78 % | 194 mil M | |
-3,69 % | 147 mil M |